spacer
spacer

PDBsum entry 2av7

Go to PDB code: 
Top Page protein ligands Protein-protein interface(s) links
Immune system PDB id
2av7
Contents
Protein chains
275 a.a.
100 a.a.
Ligands
LEU-LEU-PHE-GLY-
TYR-PRO-VAL-TYR-
VAL
×2
GOL ×20
Waters ×696

References listed in PDB file
Key reference
Title Unraveling a hotspot for tcr recognition on hla-A2: evidence against the existence of peptide-Independent tcr binding determinants.
Authors S.J.Gagnon, O.Y.Borbulevych, R.L.Davis-Harrison, T.K.Baxter, J.R.Clemens, K.M.Armstrong, R.V.Turner, M.Damirjian, W.E.Biddison, B.M.Baker.
Ref. J Mol Biol, 2005, 353, 556-573. [DOI no: 10.1016/j.jmb.2005.08.024]
PubMed id 16197958
Abstract
T cell receptor (TCR) recognition of peptide takes place in the context of the major histocompatibility complex (MHC) molecule, which accounts for approximately two-thirds of the peptide/MHC buried surface. Using the class I MHC HLA-A2 and a large panel of mutants, we have previously shown that surface mutations that disrupt TCR recognition vary with the identity of the peptide. The single exception is Lys66 on the HLA-A2 alpha1 helix, which when mutated to alanine disrupts recognition for 93% of over 250 different T cell clones or lines, independent of which peptide is bound. Thus, Lys66 could serve as a peptide-independent TCR binding determinant. Here, we have examined the role of Lys66 in TCR recognition of HLA-A2 in detail. The structure of a peptide/HLA-A2 molecule with the K66A mutation indicates that although the mutation induces no major structural changes, it results in the exposure of a negatively charged glutamate (Glu63) underneath Lys66. Concurrent replacement of Glu63 with glutamine restores TCR binding and function for T cells specific for five different peptides presented by HLA-A2. Thus, the positive charge on Lys66 does not serve to guide all TCRs onto the HLA-A2 molecule in a manner required for productive signaling. Furthermore, electrostatic calculations indicate that Lys66 does not contribute to the stability of two TCR-peptide/HLA-A2 complexes. Our findings are consistent with the notion that each TCR arrives at a unique solution of how to bind a peptide/MHC, most strongly influenced by the chemical and structural features of the bound peptide. This would not rule out an intrinsic affinity of TCRs for MHC molecules achieved through multiple weak interactions, but for HLA-A2 the collective mutational data place limits on the role of any single MHC amino acid side-chain in driving TCR binding in a peptide-independent fashion.
Figure 3.
Figure 3. The conformation of the Tax peptide in the K66A, E63Q/K66A, and wild-type Tax/HLA-A2 structures is identical. (a) and (b) 2F[o] -F[c] peptide densities contoured at 1s for the (a) K66A and (b) E63Q/K66A structures. (c) Superimposition of the Tax peptide from the K66A, E63Q/K66A, and wild-type structures. K66A is yellow, E63Q/K66A is white, and wild-type is blue.
Figure 5.
Figure 5. Effects of the K66A and E63Q/K66A mutations on electrostatic surface potentials. (a) Electrostatic potential on the surface of wild-type Tax/HLA-A2. The circled region, enlarged on the right-hand side, is characterized by a positive surface potential. (b) The K66A mutation reverses the potential at this position. (c) The E63Q/K66A double mutation results in a surface potential close to neutrality. The scale, from red to blue, is -5 to +5kT/e.
The above figures are reprinted by permission from Elsevier: J Mol Biol (2005, 353, 556-573) copyright 2005.
PROCHECK
Go to PROCHECK summary
 Headers

 

spacer

spacer